Table 3.
FMD, PORH, and arterial stiffness measures in HT and CON
Group | Pre | Mid | Post |
---|---|---|---|
Pre-IR FMD, % | |||
HT | 7.6 ± 2.8 | 9.5 ± 1.7 | 9.2 ± 2.2 |
CON | 8.7 ± 1.7 | 8.6 ± 2.8 | 8.1 ± 2.9 |
Post-IR FMD, % | |||
HT | 5.6 ± 2.7# | 8.7 ± 2.4* | 9.5 ± 1.8*† |
CON | 7.7 ± 3.6# | 6.7 ± 1.7# | 6.3 ± 2.8# |
Brachial artery diameter, cm | |||
HT | 0.315 ± 0.075 | 0.326 ± 0.072* | 0.337 ± 0.066*† |
CON | 0.302 ± 0.081 | 0.304 ± 0.084 | 0.306 ± 0.073 |
Pre-IR FMD, shear-corrected | |||
HT | 3.7 ± 0.9 | 6.3 ± 2.1* | 6.5 ± 2.5*† |
CON | 4.7 ± 1.5 | 4.2 ± 1.1 | 4.0 ± 0.8 |
Post-IR FMD, shear-corrected | |||
HT | 3.4 ± 0.9 | 5.2 ± 1.3* | 5.7 ± 2.6*† |
CON | 3.9 ± 2.5 | 3.2 ± 1.1 | 3.0 ± 1.2 |
Pre-IR peak PORH, fold ∆ | |||
HT | 1.0 ± 0 | 1.0 ± 0.1 | 1.2 ± 0.2 |
CON | 1.0 ± 0 | 1.0 ± 0.1 | 1.0 ± 0.2 |
Post-IR peak PORH, fold ∆ | |||
HT | 0.6 ± 0.2# | 0.9 ± 0.3* | 1.1 ± 0.4*† |
CON | 0.7 ± 0.2# | 0.6 ± 0.2# | 0.7 ± 0.2# |
Pre-IR AUC PORH (fold ∆) | |||
HT | 1.0 ± 0 | 1.3 ± 0.4* | 1.3 ± 0.2* |
CON | 1.0 ± 0 | 1.0 ± 0.2 | 1.0 ± 0.2 |
Post-IR AUC PORH, fold ∆ | |||
HT | 0.7 ± 0.2# | 0.9 ± 0.4 | 1.2 ± 0.4*† |
CON | 0.8 ± 0.3# | 0.7 ± 0.3# | 0.7 ± 0.3# |
Carotid-femoral PWV, cm/s | |||
HT | 698 ± 69 | 711 ± 79 | 689 ± 45 |
CON | 697 ± 59 | 690 ± 72 | 680 ± 68 |
Brachial-ankle PWV, cm/s | |||
HT | 870 ± 81 | 844 ± 95 | 798 ± 72* |
CON | 869 ± 86 | 841 ± 84 | 845 ± 82 |
Values are means ± SD. AUC, area under the curve; CON, control; FMD, flow-mediated dilation; HT, heat therapy; IR, ischemia-reperfusion; PORH, postocclusive reactive hyperemia; PWV, pulse-wave velocity.
Significant (P < 0.05) difference from Pre within group;
Significant difference (P < 0.05) from Pre-IR;
Significant difference (P < 0.05) from CON in Post.